NeuroSigma Announces Strategic Digital Marketing Partnership with Data360
LOS ANGELES, Jan. 31, 2023 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company commercializing external ...
top of page
- Dec 6, 2022
Kalos Medical Announces Promotion of Seokjoo Chang, Ph.D. to Co-Chief Executive Officer
Further Announces Engagement of Checkmate Capital Group as International Advisor LOS ANGELES and SEOUL, South Korea, Dec. 06, 2022 ...
- Nov 8, 2022
Enrollment Commences in Two Large, Double-Blind Trials of eTNS for Pediatric ADHD
Trials recruiting subjects at UCLA and Seattle Children’s Hospital in the United States, and at King’s College London and the ...
- Oct 17, 2022
NeuroSigma Announces Commercial Launch of The Monarch eTNS® System
NeuroSigma Announces Commercial Launch of The Monarch eTNS® System for the Treatment of Pediatric ADHD at Annual Meeting of the...
- Sep 27, 2022
NeuroSigma Announces Receipt of Permanent HCPCS Codes from CMS for Monarch eTNS System
LOS ANGELES, Sept. 27, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company, announced that the...
- Sep 21, 2022
Lactiga Therapeutics Raises $1.6M USD in Oversubscribed Pre-Seed Round
Lactiga Therapeutics Raises $1.6M USD in Oversubscribed Pre-Seed Round, Secures $350k in Research Grants NORTH BRUNSWICK, N.J., Sept. ...
- Sep 7, 2022
Precision Livestock Technologies Closes Preferred Equity Financing
Capital to Support Commercialization and Ongoing R&D Engages Checkmate Capital Group as Strategic Advisor PASADENA, Calif. and DALLAS,...
- Jun 26, 2022
Checkmate Capital Group and KAIST Venture Investment Holdings Announce Partnership
Checkmate Capital Group and KAIST Venture Investment Holdings Announce Partnership & Selection as TIPS Operator LOS ANGELES and SEOUL,...
bottom of page